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Abstract
Marjolin’s tumor is a term used to describe a malignancy developing in the setting of a chronic
wound, infection, or other tissue subject to chronic inflammatory changes. These malignancies
usually present after many years of chronicity, and can range from lower grade basal cell carcinomas
to high-grade sarcomas. We present the case of a squamous cell carcinoma that developed within a
chronic periprosthetic infection of a total knee arthroplasty of 7 years duration. The intra-articular
location, association with an orthopaedic implant, and brief latency period are all unique features of
this case.

Presentation
A 57 year-old female with a past medical history
of rheumatoid arthritis on long-term hydroxychloroquine and leflunomide, as well as pulmonary embolism and hypothyroidism, underwent left total knee
arthroplasty (TKA) on 9/16/2009. She developed an
acute hematogenously-seeded periprosthetic joint
infection (PJI) of unspecified organism and underwent debridement and exchange of polyethylene on
6/7/2011, followed by 6 weeks of parenteral antibiotics. She was asymptomatic after this procedure until
6/4/2012, at which time she developed a small cyst
over the knee which was excised on 12/3/2012. This
was complicated by wound healing difficulties,
necessitating a split-thickness skin grafting
procedure, which was then followed shortly by a
second PJI. She underwent a 2-stage revision with
explantation of components and antibiotic spacer
insertion on 3/8/2013, followed by spacer removal
and implantation of components on 6/4/2013. After
persistence of PJI was suspected, she was referred to a
musculoskeletal infection specialist for consultation
(Figure 1).

Figure 1. 7/30/2013. AP (A) and Lateral (B) radiographs at the time of initial
consultation demonstrating a stemmed TKA with substantial effusion and
patella alta.
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The patient underwent explantation of her TKA
and insertion of a PMMA antibiotic spacer impregnated with vancomycin and tobramycin on 9/28/2013
(Figure 2). Intraoperative cultures were positive for
Pseudomonas aeruginosa, and she was prescribed a
course of IV aztreonam and PO ciprofloxacin for 6
weeks. Her postoperative course was complicated by
a proximal tibial fracture, which was managed
uneventfully in a long leg cast. A left knee aspiration
and serologies performed on 12/10/2013 found no
evidence of persistent infection.
Revision TKA with stemmed implants was
performed on 2/6/2014 with 5 intraoperative frozen
section pathology specimens demonstrating no
evidence of infection or acute inflammation. Her
postoperative course was complicated this time by a
left lower extremity DVT despite therapeutic coumadin. After uneventful healing of her surgical wound,
chronic venous stasis changes were observed in the
lower extremity, managed with compression stockings. At a 6 month postoperative visit on 8/5/2014 the
patient reported “popping” of her knee and
radiographs demonstrated loosening around the tibial
component (Figure 3). An aspiration obtained at this
visit demonstrated 41,310 WBC’s, 97% PMN’s,
negative crystals and growth of coagulase negative
Staphylococcus in broth only. A repeat aspiration on
8/26/14 demonstrated 36,600 WBC’s, 97% PMN’s, no
crystals and growth of coagulase negative
Staphylococcus. Due to persistence of her infection now
after two 2-stage revisions, it was recommended at
this time that the patient undergo component
explantation with a knee arthrodesis and an extended
course of IV clindamycin and ciprofloxacin (Figure 4).
This was performed on 12/15/2014. Surgical site
pathology confirmed inflammatory debris.
The patient tolerated this reconstruction well
over the course of 15 months, at which point she
presented on 3/2/2016 with persistent extremity
edema that had failed aggressive conservative
management. An aspiration of the knee was negative
at this time. Over the ensuing months the patient
developed a 5cm x 3cm anterior tibial wound without
drainage or fistula formation. Local wound care was
performed without improvement in the area of
ulceration. A technetium-99m bone scan obtained on
11/11/2016 demonstrated findings consistent with
persistent osteomyelitis of the left anterior tibia. It was
recommended that the patient undergo exchange of
her arthrodesis nail and antibiotic spacer, followed by
split-thickness skin grafting of her tibial wound,
which she delayed until 5/18/2017 in favor of the
patient’s preference for observation. Intraoperative
cultures were positive for E. coli, coagulase negative
Staphylococcus, beta-lactamase positive Bacteroides, and
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Enterococcus group D. The patient was initiated on IV
aztreonam, PO doxycycline and PO metronidazole.
She continued to develop multiple anterior venous
stasis ulcerations of the left lower leg, one of which
required an additional split-thickness skin grafting on
11/16/2017 after failing conservative management.
The patient presented on 1/8/2018 with
increasing erythema, warmth, and new skin
ulcerations over the anterior left tibia. Cultures of the
ulcerations demonstrated Corynebacterium. Her
inflammatory markers at this time were elevated;
erythrocyte sedimentation rate (ESR) was 101 and
c-reactive protein (CRP) was 87.2. Plain radiographs
demonstrated progressive lytic changes of the tibia
suggestive of abscess formation and osteomyelitis
(Figure 5). A frank discussion was held regarding the
surgical options for what was becoming an increasing
compromised extremity. The patient was not
receptive to a discussion of extremity ablation at this
time, and after another period of observation, she
agreed to undergo an additional exchange of her
arthrodesis nail and antibiotic spacer.

Figure 2. 9/30/2013. Postoperative AP (A) and Lateral (B) radiographs
demonstrating appropriate alignment of the knee after explantation of
components and PMMA antibiotic spacer insertion.

Figure 3. 8/5/2014. AP (A) and Lateral (B) radiographs demonstrating
substantial effusion of the knee joint, and lucency and periprosthetic loosening
around the stemmed tibial implant.
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Figure 4. 1/20/2015. AP (A) and Lateral (B) radiographs demonstrating a
locked lower extremity arthrodesis nail through a static antibiotic cement
block.

Figure 5. 1/8/2018. AP (A) and lateral (B) radiographs demonstrating
progressive lysis of the proximal tibia below the PMMA antibiotic cement
spacer.

Figure 6. Intraoperative appearance of wound demonstrating diffuse nodular
involvement of the joint.
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On 7/5/2018 the patient returned to the
operating room for a planned exchange of her
arthrodesis rod, irrigation and debridement, and
reinsertion of antibiotic cement spacer. Intraoperative
cultures grew 3 different strains of E. coli,
Beta-lactamase positive bacteroides, and enterococcus
faecalis. Upon exposure, the tissue bed around the
proximal tibia and distal femur was observed to have
an unusual, pebble-like appearance (Figure 6).
Intraoperative frozen section pathology consultation
was obtained, returning a diagnosis of squamous cell
carcinoma (Figure 7). The wound was closed and an
orthopaedic oncology consultation was obtained.
A staging CT of the chest abdomen and pelvis
demonstrated an enlarged left inguinal lymph node
without other signs of pulmonary or locoregional
metastasis. Due to the extensive involvement and
contamination of the joint with carcinoma, as well as
the overall compromised nature of the extremity,
ablation of the extremity was recommended with
above knee amputation, combined with sentinel
lymph node biopsy, which was performed on
7/9/2018. The sentinel lymph node, measuring 6.3 by
3.5 by 2.3 cm was negative for carcinoma, and
consisted of an enlarged, reactive lymph node from
chronic infection. Margins from the skin, soft tissue,
and femoral canal were negative for malignancy. The
patient was discharged with 2 weeks of oral
doxycycline. She proceeded to heal her stump wound
uneventfully. A restaging PET-CT performed 6
months postoperatively demonstrated persistent
reactive inflammatory lymphadenopathy in the left
inguinal region, with no evidence of metastatic
disease.

Discussion
The first observation of Marjolin’s ulcer (MU) is
credited to Aurelius Cornelius Celsus in the first
century, who described malignant changes in a burn
scar.11 The term “Marjolin Ulcer” was coined by
Robert Smith in 1850, who described the pathologic
transformation of chronic wounds into malignancy.
Malignancies observed include squamous cell
carcinoma (SCC), basal cell carcinoma (BCC),
melanoma and sarcoma.7 Marjolin’s Ulcer is a rare
complication which has been observed in scar tissue,
chronic ulcers, osteomyelitis, fistulas and any wound
aggravated by persistent inflammation.11,12,17,19 The
pathophysiology of chronic wounds undergoing
malignant transformation has been debated over the
past century and no specific factor has been
identified.15 Prevailing theories suggest repetitive
tissue damage leading to cellular proliferation, prone
to spontaneous mutations. Necrotic tissue toxins may
exacerbate mutations leading to inhibited apoptosis.
http://www.jbji.net
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This is likely from a multifactorial etiology including
environmental, immunological and genetic factors
summarized in Table 1.11,13,14,15,16
Table 1.
Pathogenesis Of Marjolin’s Ulcer
Chronic irritation theory 13 Repeated re-epithelialization induced
carcinogenesis.
Traumatic epithelial
Skin grafts into the dermis prompt an
grafting theory 15
immunological response impairing physiologic
healing.
Cocarcinogen theory 17
Chemical toxins/physical injury stimulate latent
malignant cell proliferation
Initiation and promotion Two-stage process. Initiation phase where
theory 15
healthy cells turn into latent malignant cells.
Promotion phase where malignant cells
proliferate due to cocarcinogens, infection, etc.
Immunological theory 16 Sequestration of wound leads to avascularity and
impaired immune surveillance leading to
unregulated cell growth.

Epidemiology
Marjolin’s ulcer has been classically associated
with burns, reported to occur as frequently in 2% of
chronic burn scars.14 The most common malignancy
observed as Marjolin tumors is squamous cell
carcinoma (71%), followed by basal cell carcinoma
(12%), melanoma (6%), sarcoma (5%), and other
neoplasms (4%).2 The hallmark of Marjolin’s tumor is
the chronicity of the primary disease. The average
latency period is 32 years, but acute cases have been
reported with malignant transformation occurring
within 12 months.1,2 Marjolin’s ulcers most frequently
affect the extremities, with a predilection for the lower
extremities (53.3%), followed by the upper extremities
(18.7%), torso (12.4%), and head and neck (5.8%).2
Metastatic disease is observed in 32% of patients with
squamous cell carcinoma.3

Diagnosis
Any chronic wound that undergoes a change in
appearance or drainage should alert providers to the
possibility of malignant transformation. A compre-
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hensive history detailing the chronicity of the wound
as well as attempted treatments should be documented. Suspect lesions should undergo biopsy performed
by or at the direction of the treating surgeon.10 Tissue
sampling, either by percutaneous needle or incisional
biopsy, should be planned with the definitive
resection in mind.12 After histologic confirmation of
malignancy, staging by way of local MRI and body CT
or PET scan are recommended to identify lymph node
and distant metastases.10 Staging provides a
reproducible way to communicate disease burden
and provides prognostic information.10

Treatment
Once the diagnosis of Marjolin’s ulcer is confirmed, collaboration with a multidisciplinary
oncology team will ensure that general recommendations proposed by the AJCC will be followed.10
Localized disease is generally managed with wide
local excision with 2-4 cm negative margins.10,16, 17, 18
High-risk tumors with extensive soft tissue or bone
involvement, or locoregional lymph node spread may
be best managed with amputation. Distant metastases
may require resection, intensity-modulated radiotherapy, or systemic chemotherapy as determined by
the
multidisciplinary
oncology
team9.
Routinely-scheduled
surveillance
studies
are
monitored by the oncology team.
Our case report presents several unique features
to the Marjolin’s tumor. This mass developed as a
consequence of long-standing periprosthetic joint
infection in an immunosuppressed host, with a
latency period of only 7 years, and an even shorter
period of off-and-on wound drainage. Furthermore
this malignancy developed in an intraosseous and
intra-articular location, without superficial skin
involvement. The case patient was fortunate, in that
her locoregional lymphadenopathy was reactive in
nature secondary to infection, and not consistent with
metastatic spread. Ablation of the extremity was
therefore potentially curative.

Figure 7. Hematoxylin and eosin histopathology at Low (100x) (A) and High (200x) (B) power imaging demonstrating squamous cell carcinoma, with nests of
epithelioid cells and distinguishing keratinous debris
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Figure 8. Algorithm for diagnosis and management of Marjolin tumor.

Conclusion
Marjolin’s Ulcers are frequently aggressive
tumors complicating chronically infected wounds and
tissues of the extremities. To our knowledge, the
incidence of malignant transformation in chronic
periprosthetic joint infection is unknown. This
unusual complication was identified intraoperatively
by the recognition of a tissue bed with an atypical
appearance, which highlights the importance of
maintaining a high index of suspicion when managing chronic musculoskeletal infection. Consistent with
the adage “culture what you biopsy and biopsy what
you culture,” this case confirms that it is prudent to
send material for histopathologic examination when
performing debridement procedures, particularly
when the appearance of the wound bed or drainage
have changed.
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